USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$2.85M
Market Cap
-
P/E Ratio
-179.34
EPS
$2,196.00
52 Week High
$1.48
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$457K |
| Total Revenue | $922M |
| Cost Of Revenue | $457K |
| Costof Goods And Services Sold | $457K |
| Operating Income | -$15M |
| Selling General And Administrative | $12M |
| Research And Development | $3.4M |
| Operating Expenses | $15M |
| Investment Income Net | - |
| Net Interest Income | -$1.5M |
| Interest Income | $13K |
| Interest Expense | $1.5M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $457K |
| Income Before Tax | -$18M |
| Income Tax Expense | -$30M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$18M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$16M |
| Ebitda | -$16M |
| Net Income | -$18M |
| Field | Value (USD) |
|---|---|
| Total Assets | $4.2M |
| Total Current Assets | $2.7M |
| Cash And Cash Equivalents At Carrying Value | $554K |
| Cash And Short Term Investments | $554K |
| Inventory | $343M |
| Current Net Receivables | $489K |
| Total Non Current Assets | $1.5M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $419M |
| Intangible Assets Excluding Goodwill | $419M |
| Goodwill | $1B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $370M |
| Other Current Assets | $1.7M |
| Other Non Current Assets | - |
| Total Liabilities | $11M |
| Total Current Liabilities | $11M |
| Current Accounts Payable | $1.4M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $7.4M |
| Total Non Current Liabilities | $245K |
| Capital Lease Obligations | $226K |
| Long Term Debt | - |
| Current Long Term Debt | $7.2M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $7.5M |
| Other Current Liabilities | $2M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | -$6.8M |
| Treasury Stock | - |
| Retained Earnings | -$29M |
| Common Stock | $14K |
| Common Stock Shares Outstanding | $7.2K |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$457K |
| Total Revenue | $922M |
| Cost Of Revenue | $457K |
| Costof Goods And Services Sold | $457K |
| Operating Income | -$15M |
| Selling General And Administrative | $12M |
| Research And Development | $3.4M |
| Operating Expenses | $15M |
| Investment Income Net | - |
| Net Interest Income | -$1.5M |
| Interest Income | $13K |
| Interest Expense | $1.5M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $457K |
| Income Before Tax | -$18M |
| Income Tax Expense | -$30M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$18M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$16M |
| Ebitda | -$16M |
| Net Income | -$18M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None